African Union drops plans to buy Covid vaccines from Serum, pivots to J&J

The AstraZeneca vaccine, sold under the brand name Covishield. Photo: Shutterstock
The African Union has dropped plans to secure COVID-19 vaccines from the Serum Institute of India for African nations and is exploring options with Johnson & Johnson, the head of the Africa Centres for Disease Control and Prevention said on Thursday.

 
The institute will still supply the AstraZeneca vaccine to Africa through the COVAX vaccine-sharing facility, John Nkengasong told reporters, but the African Union would seek additional supplies from Johnson & Johnson.

 
The statement comes the day after European and British medicine regulators said they had found possible links between AstraZeneca's vaccine and reports of very rare cases of brain blood clots, but they reaffirmed its importance in protecting people.

 
Nkengasong said the possible link had nothing to do with the African Union's decision. The bloc of 55 member states shifted its efforts to the Johnson & Johnson vaccine, he said, citing the deal signed last week to secure up to 400 million doses beginning in the third quarter of this year.

 
"...It was just a clear understanding of how not to duplicate efforts with the Serum Institute, so that we compliment each other rather than duplicate efforts," he said.


Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel